Gen QA

MEMBER LOGIN

MENU menu

Close close menu

Chronic Lymphocytic Leukaemia (CLL) IGHV mutation status

BACK TO EQA DIRECTORY

Analysis for IGHV mutation status in chronic lymphocytic leukaemia samples: DNA and lyophilised cells.

EQA INFORMATION

EQA Code
HCLLI
Submission
Clinical Report
Techniques
Any methodology
Eligibility
Any ERIC certified laboratory for IGHV testing. Non certified laboratories please contact GenQA.
Language
English, French, German, Italian, Polish, Portuguese, Spanish
EQA Accreditation
EQA accredited to ISO 17043:2023
EQA open

01 September 2025

Testing period
6 weeks

OTHER INFORMATION

This EQA is offered in collaboration with UK NEQAS Leucocyte Immunophenotyping (UK NEQAS LI).  Additional details can be found under MORE INFORMATION.  

What are participants required to do?
  • Enrolled participants will receive details by email when an EQA is open for assessment and/or samples have been dispatched.  
  • Participants are expected to access the instructions and information for the cases/samples online and to analyse them according to their laboratory/centre protocols. 
  • Participants must submit their anonymised results by the deadline using their standard laboratory report or a proforma provided by GenQA.  The submitted results are independently assessed for the accuracy of the analytical/genotyping results, clinical interpretation of the results (if appropriate) and clerical accuracy (including report layout and content).  The submissions will be assessed against ERIC recommendations. 

What can I expect as a participant?
Every participant will receive:
  • An Individual Laboratory/Centre Report (ILR/ICR) with educational advice for each distribution of this EQA.
  • The Summary report for each distribution of this EQA which contains information regarding general findings, a summary of methodologies used, common errors, number of participants and benchmarking. 
  • Access to a live Performance Certificate summarising your performance status for all EQAs in which you are enrolled.
 
Please note: EQA details may be subject to change prior to EQA distribution. 

PRODUCTS

Sample type: DNA in TE buffer, Cells: lyophilised, cDNA (please contact GenQA if required)
Testing/analysis: IGHV mutation status
Conditions/Gene target(s):
  • Chronic Lymphocytic Leukaemia (CLL)
  • IGHV
Number of cases: Three

LOGIN TO PURCHASE

MORE INFORMATION

 

ASK A QUESTION

Chronic Lymphocytic Leukaemia (CLL) IGHV mutation status

Enter your details here: